Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Weight losing medicament

A technology of pharmaceuticals and raw materials, applied in the field of weight loss pharmaceuticals, can solve the problems of dieting and weight loss, high cost of weight loss, and physical disadvantages, and achieve the effects of shortening absorption time, reducing blood lipids, and weak side effects

Active Publication Date: 2014-07-30
温军海
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, for most young women, exercising to lose weight is too tiring to persist, and the cost of drinking tea to lose weight is too high, and most people do not have the habit of drinking tea
[0006] Dieting to lose weight is painful, unscientific, and very detrimental to the body

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Weight losing medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Phenformin 30mg, orlistat 120mg, bisacodyl 5mg.

Embodiment 2

[0033] Phenformin 100mg, orlistat 1000mg, bisacodyl 10mg.

Embodiment 3

[0035] Phenformin 180mg, orlistat 1200mg, bisacodyl 12mg.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a weight losing medicament which comprises phenformin in a pharmaceutical salt form, orlistat and bisacodyl, wherein an effective dosage range of the phenformin is 20mg to 200mg per day; an effective dosage range of the orlistat is 20mg to 1500mg per day; an effective dosage range of the bisacodyl is 5mg to 15mg per day. The weight losing medicament is prepared by the following steps: mixing various components uniformly, and preparing one or several dosage forms in tablets, capsules and oral liquid mixtures to be taken or sequentially taken. Due to the phenformin, orlistat, bisacodyl and medicinal carriers, the weight losing medicament has the effects of inhibiting absorption of the intestinal tract on glucose and fat in foods, reducing blood fat, accelerating metabolism of muscles, fat and other peripheral tissues on the glucose, enhancing reflective peristalsis of rectum to accelerate excrement elimination and shortening the absorption time of the intestinal tract on sugar and fat; abdominal distension, stomachache, diarrhea and other combined effect mechanisms caused by bacteria glycolysis aerogenesis increase because the residence time of sugar and fat which are not absorbed by orlistat in the intestinal tract is extremely long are avoided, so that an aim of losing weight is achieved.

Description

Technical field [0001] The invention relates to the technical field of medicaments, in particular to a weight loss medicament and a method of use thereof. Background technique [0002] With the development of society and the improvement of people's living standards, obesity has become a common phenomenon. Obesity refers to a certain degree of obvious overweight and thick fat layer, which is a state caused by excessive accumulation of body fat, especially triglycerides. [0003] Excessive food intake or changes in the body's metabolism lead to excessive accumulation of fat in the body, resulting in excessive weight gain and causing pathological, physiological changes or latency in the body. Obesity has the following hazards: 1. Increase the risk of cardiovascular disease; 2. affect the function of the digestive system; 3. affect the function of the endocrine system; 4. increase the risk of cancer; 5. In addition, there are joint soft tissue damage and reproductive ability Decline ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4402A61P3/04A61P3/06A61P3/10A61P9/12A61P1/10A61K31/365A61K31/155
Inventor 温军海段丽杰
Owner 温军海
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products